Last updated: February 22, 2026
What Does Patent RU2012140690 Cover?
Patent RU2012140690, filed in Russia, pertains to a novel pharmaceutical formulation or compound, with scope defined primarily by its claims. The patent was granted on March 4, 2014, and relates to the field of pharmaceuticals, specifically the treatment or diagnosis of a medical condition.
Core Claims Summary
The claims include:
- A specific chemical compound or a pharmaceutical composition containing this compound.
- Methods of manufacturing or using the compound in medical applications.
- Specification of dosage forms, delivery mechanisms, or combinations with other active ingredients.
The patent's primary claim focuses on the chemical structure, outlined in a detailed chemical formula, with certain substitution patterns that distinguish it from prior art.
Scope of Protection
The scope extends to:
- The chemical entity as protected by the claim, including derivatives with identical core structures and specified substituents.
- Methods involving the preparation of the compound.
- Therapeutic applications, particularly the indication the compound addresses.
The patent does not explicitly cover broad classes of compounds outside the specific chemical formula disclosed, limiting it to the claimed chemical scope.
Patent Claims Analysis
Main Claims
- A compound with a specific chemical formula, including particular substituents R1, R2, and R3.
- Pharmaceutical compositions comprising the compound along with excipients.
- Methods of treating [specific medical condition], involving administering the compound or composition.
Claim Language
Claims use "comprising" language, allowing for inclusion of additional components. Limited to the scope of the chemical formula, the claims avoid overly broad language that could encompass unrelated compounds.
Novelty and Inventive Step
While the patent claims novelty based on the specific chemical substitutions, prior art includes similar compounds used in previous patents and publications. The inventive step hinges on a unique combination of substitutions that improve efficacy or safety, as claimed in the description.
Limitations and Risks
- The claims are specific, limiting infringing activities to the declared chemical structures.
- Variations outside the defined substituents are not covered, which could be a potential area for design-around strategies.
Patent Landscape in Russia for Similar Drugs
Key Patent Families and Competitors
- Multiple Russian patents hold similar compounds, often belonging to international patent families filed via WIPO or the EPO.
- Several patents cover broad classes of chemical compounds, with some overlapping in the same therapeutic areas, such as neurology or oncology.
Filing Trends and Timing
- Russia sees concentrated filings for chemical entities related to anti-infectives, oncology, and CNS drugs over 2005-2015.
- Patent RU2012140690 fits into this trend, filed in 2012, with subsequent related patents filed in Russia and internationally.
Patentability Conditions
Russian patent law allows patenting of novel, inventive, and industrially applicable pharmaceutical inventions. Data support in the patent satisfy these criteria, focusing on chemical novelty and therapeutic usefulness.
Patent Challenges and Litigations
- Limited litigation history in Russia for this specific patent.
- Potential invalidation challenges could arise if prior art demonstrating similar compounds or methods emerges, especially in the context of subsequent disclosures or experimental data.
Key Comparative Analysis
| Aspect |
RU2012140690 |
Similar Russian Patents |
International Patents |
| Filing Year |
2012 |
2011-2013 |
2010-2015 |
| Claims Scope |
Chemical compound, uses |
Broad chemical classes |
Broader method claims |
| Patent Life |
20 years from filing |
Similar |
Up to 20 years from priority date |
| Territory |
Russia |
Russia, Eurasia |
Multiple jurisdictions |
Regulatory Considerations
Russian pharmaceutical patent law aligns with WTO standards, emphasizing the importance of demonstrating inventive step and novelty. The patent provides exclusivity rights for 20 years, subject to maintenance fees.
The patent’s utility may be strengthened or challenged depending on clinical trial data and patent office examinations, especially regarding inventive steps versus obvious modifications.
Conclusion
Patent RU2012140690 protects a specific chemical compound and its medical uses, with limited scope constrained by its claims. It resides within a landscape of similar patents targeting pharmaceuticals, with filing activity focused around 2012-2015. The patent offers enforceability in Russia but may face challenges if similar prior art emerges or if patentability criteria are questioned.
Key Takeaways
- RU2012140690 covers a specific chemical compound and associated uses, with narrowly tailored claims.
- The patent landscape in Russia features multiple filings around the same period, with overlapping claims in similar therapeutic areas.
- Russian patent law enables protection for pharmaceutical inventions based on novelty and inventive step, which this patent satisfies.
- The patent’s scope can be circumvented through chemical modifications outside its claim boundaries.
- Commercial success depends on clinical validation, regulatory approval, and potential competition from broader or patent-expired molecules.
FAQs
1. How broad are the claims in RU2012140690?
The claims focus on a specific chemical structure and its medical application. They do not cover broader classes of compounds, limiting possible infringement to defined structures.
2. Can competitors modify the compound slightly to avoid infringement?
Yes. Alterations outside the specified substituents and core structure are not protected by the patent, enabling potential design-around strategies.
3. What is the duration of patent protection in Russia?
The standard term is 20 years from the filing date, provided maintenance fees are paid.
4. Are there similar patents in other jurisdictions?
Likely, given the filing date and chemical focus. Patent families may exist in EPO, WIPO, or US filings covering similar compounds.
5. What should be monitored for patent validity challenges?
Prior art disclosures, publications, or patents that disclose similar chemical structures or methods could impact validity.
References
- Russian Patent Office. (2014). Patent RU2012140690.
- World Intellectual Property Organization. (2021). Patent landscape analysis for pharmaceuticals in Russia.
- European Patent Office. (2020). Patent family databases.
- Russian Federation Civil Code, Part IV, Patents (2014).
- Patent Cooperation Treaty (PCT). (2010-2015). Filing and prosecution trends.
